271 related articles for article (PubMed ID: 23615276)
1. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets.
Dant JT; Richardson RB; Nie LH
Phys Med Biol; 2013 May; 58(10):3301-19. PubMed ID: 23615276
[TBL] [Abstract][Full Text] [Related]
2. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
Sadremomtaz A; Masoumi M
J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose to trabecular bone marrow stem cells from (3)H, (14)C and selected alpha-emitters incorporated in a bone remodeling compartment.
Nie H; Richardson RB
Phys Med Biol; 2009 Feb; 54(4):963-79. PubMed ID: 19147899
[TBL] [Abstract][Full Text] [Related]
4. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
[TBL] [Abstract][Full Text] [Related]
5. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
6. [Estimation of the energy fraction emitted by alpha particles in the mineralized part of trabecular bone which is absorbed in the bone marrow].
Franić Z
Arh Hig Rada Toksikol; 1989 Mar; 40(1):29-36. PubMed ID: 2803007
[TBL] [Abstract][Full Text] [Related]
7. Concerning the health effects of internally deposited radionuclides.
Raabe OG
Health Phys; 2010 Mar; 98(3):515-36. PubMed ID: 20147792
[TBL] [Abstract][Full Text] [Related]
8. Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow.
Tranel J; Feng FY; James SS; Hope TA
Phys Med Biol; 2021 Jan; 66(3):035016. PubMed ID: 33321484
[TBL] [Abstract][Full Text] [Related]
9. Magnetically enhanced protection of bone marrow from beta particles emitted by bone-seeking radionuclides: theory of application.
Raylman RR; Wahl RL
Med Phys; 1995 Aug; 22(8):1285-92. PubMed ID: 7476715
[TBL] [Abstract][Full Text] [Related]
10. Alpha-particle doses to cells of the bone remodeling cycle from alpha-particle-emitting bone-seekers: indications of an antiresorptive effect of actinides.
Salmon PL; Onischuk YN; Bondarenko OA; Lanyon LE
Radiat Res; 1999 Dec; 152(6 Suppl):S43-7. PubMed ID: 10564935
[TBL] [Abstract][Full Text] [Related]
11. Stochastic parametric skeletal dosimetry model for humans: General approach and application to active marrow exposure from bone-seeking beta-particle emitters.
Degteva MO; Tolstykh EI; Shishkina EA; Sharagin PA; Zalyapin VI; Volchkova AY; Smith MA; Napier BA
PLoS One; 2021; 16(10):e0257605. PubMed ID: 34648511
[TBL] [Abstract][Full Text] [Related]
12. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
[TBL] [Abstract][Full Text] [Related]
13. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo determination of age-dependent steady-state dose to red bone marrow and bone from 14C exposure.
Richardson RB; Dubeau J
Radiat Prot Dosimetry; 2003; 103(1):5-18. PubMed ID: 12596984
[TBL] [Abstract][Full Text] [Related]
15. Modeling energy deposition in trabecular spongiosa using the Monte Carlo code PENELOPE.
Gersh JA; Dingfelder M; Toburen LH
Health Phys; 2007 Jul; 93(1):47-59. PubMed ID: 17563492
[TBL] [Abstract][Full Text] [Related]
16. A three-dimensional transport model for determining absorbed fractions of energy for electrons within trabecular bone.
Bouchet LG; Jokisch DW; Bolch WE
J Nucl Med; 1999 Nov; 40(11):1947-66. PubMed ID: 10565793
[TBL] [Abstract][Full Text] [Related]
17. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.
Henriksen G; Fisher DR; Roeske JC; Bruland ØS; Larsen RH
J Nucl Med; 2003 Feb; 44(2):252-9. PubMed ID: 12571218
[TBL] [Abstract][Full Text] [Related]
18. Considerations of marrow cellularity in 3-dimensional dosimetric models of the trabecular skeleton.
Bolch WE; Patton PW; Rajon DA; Shah AP; Jokisch DW; Inglis BA
J Nucl Med; 2002 Jan; 43(1):97-108. PubMed ID: 11801712
[TBL] [Abstract][Full Text] [Related]
19. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
20. Temporal change in microdosimetry to bone marrow and stromal progenitor cells from alpha-particle-emitting radionuclides incorporated in bone.
Austin AL; Ellender M; Haines JW; Harrison JD; Lord BI
Radiat Res; 1999 Dec; 152(6 Suppl):S38-42. PubMed ID: 10564934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
